anidulafungin
Selected indexed studies
- Echinocandins Pharmacokinetics: A Comprehensive Review of Micafungin, Caspofungin, Anidulafungin, and Rezafungin Population Pharmacokinetic Models and Dose Optimization in Special Populations. (Clin Pharmacokinet, 2025) [PMID:39707078]
- [Anidulafungin]. (Rev Esp Quimioter, 2008) [PMID:18509769]
- Anidulafungin: a novel echinocandin. (Clin Infect Dis, 2006) [PMID:16779750]
_Worker-drafted node — pending editorial review._
Connections
anidulafungin is a side effect of
Sources
- Echinocandins Pharmacokinetics: A Comprehensive Review of Micafungin, Caspofungin, Anidulafungin, and Rezafungin Population Pharmacokinetic Models and Dose Optimization in Special Populations. (2025) pubmed
- [Anidulafungin]. (2008) pubmed
- Anidulafungin: a novel echinocandin. (2006) pubmed
- Anidulafungin. (2004) pubmed
- Anidulafungin Vicuron. (2003) pubmed
- Anidulafungin: a new echinocandin with a novel profile. (2005) pubmed
- Anidulafungin: an echinocandin antifungal. (2004) pubmed
- Anidulafungin, a new echinocandin: in vitro activity. (2009) pubmed
- Anidulafungin: ECB, LY 303366, V-echinocandin, VEC, VER 002, VER-02. (2003) pubmed
- Anidulafungin: when and how? The clinician's view. (2012) pubmed